Richardson, P. G., Perrot, A., Miguel, J. S., Beksac, M., Spicka, I., Leleu, X., Schjesvold, F., Moreau, P., Dimopoulos, M. A., Huang, S.-Y., Minarik, J., Cavo, M., Prince, H. M., Macé, S., Zhang, R., Dubin, F., Morisse, M. C. and Anderson, K. C. (2020) “Isatuximab-pomalidomide-dexamethasone <i>versus</i&gt; pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284325.